Molecular and pathological profiling of corresponding treatment-naïve and neoadjuvant pazopanib-treated high-risk soft tissue sarcoma samples of the GISG-04/NOPASS study

BRAF V600E; CDK4; MAP2K1 E203K; NGS; STS; next generation sequencing; pazopanib; soft tissue sarcoma

Saved in:
Bibliographic Details
Main Authors: Gaiser, Timo (Author) , Sauer, Christian (Author) , Marx, Alexander (Author) , Jakob, Jens (Author) , Kasper, Bernd (Author) , Hohenberger, Peter (Author) , Hirsch, Daniela (Author) , Ronellenfitsch, Ulrich (Author)
Format: Article (Journal)
Language:English
Published: 9 July 2021
In: Biology
Year: 2021, Volume: 10, Issue: 7, Pages: 1-9
ISSN:2079-7737
DOI:10.3390/biology10070639
Online Access:Resolving-System, kostenfrei: https://dx.doi.org/10.3390/biology10070639
Get full text
Author Notes:Timo Gaiser, Christian Sauer, Alexander Marx, Jens Jakob, Bernd Kasper, Peter Hohenberger, Daniela Hirsch and Ulrich Ronellenfitsch
Description
Summary:BRAF V600E; CDK4; MAP2K1 E203K; NGS; STS; next generation sequencing; pazopanib; soft tissue sarcoma
Physical Description:Online Resource
ISSN:2079-7737
DOI:10.3390/biology10070639